Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-01-05 @ 5:33 PM
Study NCT ID:
NCT03738956
Status:
UNKNOWN
Last Update Posted:
2018-11-13
First Post:
2018-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial
Sponsor:
Globe Pharmaceuticals Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-08
First Submit QC Date:
None
Study First Post Date:
2018-11-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-08
Last Update Post Date:
2018-11-13
Last Update Post Date Type:
ACTUAL